Marie Petit

598 total citations
21 papers, 480 citations indexed

About

Marie Petit is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Marie Petit has authored 21 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Marie Petit's work include Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Marie Petit is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Marie Petit collaborates with scholars based in France, Germany and Italy. Marie Petit's co-authors include F. Capel, C. Dauguet, Michael P. Manns, Dina Kremsdorf, Guido Gerken, Christian Bréchot, Karl‐Herrmann Meyer zum Büschenfelde, Sylvie Dubanchet, Luciano Sagliocca and Â.R. Zanetti and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

Marie Petit

20 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Petit France 11 332 289 63 61 54 21 480
Susana de Lucas Spain 11 306 0.9× 316 1.1× 70 1.1× 74 1.2× 124 2.3× 13 591
Hideko Nuriya Japan 11 177 0.5× 151 0.5× 163 2.6× 25 0.4× 131 2.4× 14 423
Michelle Chung United States 6 193 0.6× 167 0.6× 145 2.3× 38 0.6× 129 2.4× 9 458
Hideyuki Kato Japan 9 162 0.5× 85 0.3× 73 1.2× 72 1.2× 102 1.9× 17 392
Noha G. Bader El Din Egypt 15 350 1.1× 364 1.3× 81 1.3× 33 0.5× 167 3.1× 47 614
Maarten Penning Netherlands 11 246 0.7× 285 1.0× 39 0.6× 91 1.5× 183 3.4× 19 565
Jujin Satoi United States 7 213 0.6× 286 1.0× 37 0.6× 25 0.4× 67 1.2× 7 382
Ronda K. Sapp United States 7 405 1.2× 480 1.7× 82 1.3× 37 0.6× 75 1.4× 8 574
Yuki Nishimura‐Sakurai Japan 12 258 0.8× 286 1.0× 223 3.5× 124 2.0× 172 3.2× 18 617
M.C. Jung Germany 11 333 1.0× 435 1.5× 165 2.6× 27 0.4× 57 1.1× 18 539

Countries citing papers authored by Marie Petit

Since Specialization
Citations

This map shows the geographic impact of Marie Petit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Petit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Petit more than expected).

Fields of papers citing papers by Marie Petit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Petit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Petit. The network helps show where Marie Petit may publish in the future.

Co-authorship network of co-authors of Marie Petit

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Petit. A scholar is included among the top collaborators of Marie Petit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Petit. Marie Petit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petit, Marie, Carole Burel, Maud Maho‐Vaillant, et al.. (2022). IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab. Biomedicines. 10(8). 1774–1774. 6 indexed citations
2.
Golinski, Marie-Laure, Maud Maho‐Vaillant, Laurent Drouot, et al.. (2022). The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab. Frontiers in Immunology. 13. 849790–849790. 4 indexed citations
3.
Maho‐Vaillant, Maud, Corine Pérals, Marie-Laure Golinski, et al.. (2021). Rituximab and Corticosteroid Effect on Desmoglein-Specific B Cells and Desmoglein-Specific T Follicular Helper Cells in Pemphigus. Journal of Investigative Dermatology. 141(9). 2132–2140.e1. 18 indexed citations
4.
Petit, Marie, Damien Schapman, Marie-Laure Golinski, et al.. (2021). Longitudinal Pathogenic Properties and N-Glycosylation Profile of Antibodies from Patients with Pemphigus after Corticosteroid Treatment. Biomedicines. 9(10). 1411–1411. 2 indexed citations
5.
Hébert, V., Maud Maho‐Vaillant, Marie-Laure Golinski, et al.. (2021). Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen. Frontiers in Immunology. 12. 666022–666022. 8 indexed citations
6.
Hébert, V., Marie Petit, Maud Maho‐Vaillant, et al.. (2019). Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen. Frontiers in Immunology. 10. 1794–1794. 18 indexed citations
7.
Petit, Marie, Anne‐Laure Guihot, Linda Grimaud, et al.. (2016). Resveratrol Improved Flow-Mediated Outward Arterial Remodeling in Ovariectomized Rats with Hypertrophic Effect at High Dose. PLoS ONE. 11(1). e0146148–e0146148. 3 indexed citations
8.
Thiolat, Allan, Anne Denys, Marie Petit, et al.. (2014). Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice. Cytokine. 69(1). 87–93. 43 indexed citations
9.
Bergès, Raphaël, Nathalie Baeza-Kallee, Émeline Tabouret, et al.. (2014). End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes toVinca-alkaloidsin vitroandin vivo. Oncotarget. 5(24). 12769–12787. 23 indexed citations
10.
Gheit, Tarik, Lucyna Cova, Michèle Chevallier, et al.. (2002). Experimental transfection of macaca sylvanus with cloned human hepatitis B virus. Journal of Hepatology. 36. 23–23. 4 indexed citations
11.
Gheit, Tarik, Lucyna Cova, Michèle Chevallier, et al.. (2002). Experimental transfection of Macaca sylvanus with cloned human hepatitis B virus. Journal of General Virology. 83(7). 1645–1649. 15 indexed citations
12.
Pollicino, Teresa, Â.R. Zanetti, Irene Cacciola, et al.. (1997). Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology. 26(2). 495–499. 92 indexed citations
13.
Dubanchet, Sylvie, et al.. (1996). Suppressive effect of hepatitis B virus on the induction of interleukin-1 beta and interleukin-6 gene expression in the THP-1 human monocytic cell line.. PubMed. 7(4). 793–800. 13 indexed citations
14.
Zoulim, Fabien, F. Capel, Pascale Berthillon, C. Trépo, & Marie Petit. (1995). [Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B].. PubMed. 19(12). 970–5. 3 indexed citations
15.
Trépo, C., Fabien Zoulim, Cristina Alonso, et al.. (1993). Diagnostic markers of viral hepatitis B and C.. Gut. 34(2 Suppl). S20–S25. 20 indexed citations
16.
Gerken, Guido, Dina Kremsdorf, F. Capel, et al.. (1991). Hepatitis B defective virus with rearrangements in the PreS gene during chronic HBV infection. Virology. 183(2). 555–565. 119 indexed citations
17.
Chemin, Isabelle, Marie Petit, Fabien Zoulim, et al.. (1991). Correlation between HBV DNA detection by polymerase chain reaction and pre‐S1 antigenemia in symptomatic and asymptomatic hepatitis B virus infections. Journal of Medical Virology. 33(1). 51–57. 32 indexed citations
18.
Capel, F., et al.. (1990). In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus. Journal of Virology. 64(6). 3025–3032. 54 indexed citations
19.
20.
Jean, R, et al.. (1960). [Accidents induced by isoniazid during prolonged treatments of tuberculosis in children. I. Clinical study. II. Interpretation. III. Biological results].. PubMed. 15. 623–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susana de Lucas Breakdown of academic impact, for papers by Hideko Nuriya Breakdown of academic impact, for papers by Michelle Chung Breakdown of academic impact, for papers by Hideyuki Kato Breakdown of academic impact, for papers by Noha G. Bader El Din Breakdown of academic impact, for papers by Maarten Penning Breakdown of academic impact, for papers by Jujin Satoi Breakdown of academic impact, for papers by Ronda K. Sapp Breakdown of academic impact, for papers by Yuki Nishimura‐Sakurai Breakdown of academic impact, for papers by M.C. Jung
Rankless by CCL
2026